Nuzenio

Yahoo Moleculin

Yahoo Moleculin news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Moleculin reports interim results from MIRACLE trial in r/r AML patients - YahooYahoo · Mon, 03 Aug 2026 09:51:21 GMTMoleculin Announces Pricing of $9.3 Million Public Offering - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTMoleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTMoleculin Biotech Files Registration Statement for Public Offering; Shares Fall - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Mon, 03 Aug 2026 09:51:21 GMTMoleculin reports interim results from MIRACLE trial in r/r AML patients - Yahoo
Fri, 31 Jul 2026 07:00:00 GMTMoleculin Announces Pricing of $9.3 Million Public Offering - Yahoo Finance
Fri, 31 Jul 2026 07:00:00 GMTMoleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - Yahoo Finance
Wed, 29 Jul 2026 07:00:00 GMTMoleculin Biotech Files Registration Statement for Public Offering; Shares Fall - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Yahoo Moleculin.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.